The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
Open accessAbstract
The tumor microenvironment is a complex system, playing an important role in tumor development and progression. Besides cellular stromal components, extracellular matrix fibers, cytokines, and other metabolic mediators are also involved. In this review we outline the potential role of hypoxia, a major feature of most solid tumors, within the tumor microenvironment and how it contributes to immune resistance and immune suppression/tolerance and can be detrimental to antitumor effector cell functions. We also outline how hypoxic stress influences immunosuppressive pathways involving macrophages, myeloid-derived suppressor cells, T regulatory cells, and immune checkpoints and how it may confer tumor resistance. Finally, we discuss how microenvironmental hypoxia poses both obstacles and opportunities for new therapeutic immune interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
Cancer Metastasis: Building a Framework
Gupta, G. P., & Massagué, J. (2006) · Cell · doi:10.1016/j.cell.2006.11.001 · Cited by 4,247
Interleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2499 · Cited by 3,429
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Pàez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Viñals, F., Inoue, M., Bergers, G., Hanahan, D., & Casanovas, O. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.027 · Cited by 2,339
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
Self-citationGabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Applying the principles of stem-cell biology to cancer
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1232 · Cited by 1,624
Normalization of the Vasculature for Treatment of Cancer and Other Diseases
Goel, S., Duda, D. G., Xu, L., Munn, L. L., Boucher, Y., Fukumura, D., & Jain, R. K. (2011) · Physiological Reviews · doi:10.1152/physrev.00038.2010 · Cited by 1,605
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Semenza, G. L. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.01.005 · Cited by 1,514
Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
Facciabene, A., Peng, X., Hagemann, I. S., Balint, K., Barchetti, A., Wang, L.-P., Gimotty, P. A., Gilks, C. B., Lal, P., Zhang, L., et al. (2011) · Nature · doi:10.1038/nature10169 · Cited by 1,376
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Parsa, A. T., Waldron, J. S., Panner, A., Crane, C. A., Parney, I. F., Barry, J. J., Cachola, K. E., Murray, J. C., Tihan, T., Jensen, M. C., et al. (2007) · Nature Medicine · doi:10.1038/nm1517 · Cited by 1,344
Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity
Curiel, T. J., Wei, S., Dong, H., Alvarez, X., Cheng, P., Mottram, P., Krzysiek, R., Knutson, K. L., Daniel, B., Zimmermann, M. C., et al. (2003) · Nature Medicine · doi:10.1038/nm863 · Cited by 1,314
Wymann, M. P., & Schneiter, R. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2335 · Cited by 1,291
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Keith, B., & Simon, M. C. (2007) · Cell · doi:10.1016/j.cell.2007.04.019 · Cited by 1,179
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Klug, F., Prakash, H., Huber, P. E., Seibel, T., Bender, N., Halama, N., Pfirschke, C., Voss, R. H., Timke, C., Umansky, L., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.09.014 · Cited by 1,099
Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998) · Blood · doi:10.1182/blood.v92.11.4150 · Cited by 1,048
Mechanisms and functional significance of tumour-induced dendritic-cell defects
Gabrilovich, D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1498 · Cited by 1,024
Chen, L., Gibbons, D. L., Goswami, S., Cortez, M. A., Ahn, Y.-H., Byers, L. A., Zhang, X., Yi, X., Dwyer, D., Lin, W., et al. (2014) · Nature Communications · doi:10.1038/ncomms6241 · Cited by 966
Hydroxylation of HIF-1: Oxygen Sensing at the Molecular Level
Semenza, G. L. (2004) · Physiology · doi:10.1152/physiol.00001.2004 · Cited by 905
Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells
Kudo-Saito, C., Shirako, H., Takeuchi, T., & Kawakami, Y. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.023 · Cited by 870
Notch signaling mediates hypoxia-induced tumor cell migration and invasion
Sahlgren, C., Gustafsson, M. V., Jin, S., Poellinger, L., & Lendahl, U. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802047105 · Cited by 823
Heddleston, J. M., Li, Z., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Cell Cycle · doi:10.4161/cc.8.20.9701 · Cited by 813
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells
Barsoum, I. B., Smallwood, C. A., Siemens, D. R., & Graham, C. H. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-0992 · Cited by 767
Morrison, S. J., Perez, S. E., Qiao, Z., Verdi, J. M., Hicks, C., Weinmaster, G., & Anderson, D. J. (2000) · Cell · doi:10.1016/s0092-8674(00)80860-0 · Cited by 721
Terme, M., Pernot, S., Marcheteau, E., Sandoval, F., Benhamouda, N., Colussi, O., Dubreuil, O., Carpentier, A. F., Tartour, E., & Taieb, J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2325 · Cited by 684
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen
Doedens, A. L., Phan, A. T., Stradner, M. H., Fujimoto, J. K., Nguyen, J. V., Yang, E., Johnson, R. S., & Goldrath, A. W. (2013) · Nature Immunology · doi:10.1038/ni.2714 · Cited by 660 · cited 6×
“Vhldeficient CD8 T cells isolated from mice expressed more IFN- and TNF (27).”
BackgroundInfluentialDoedens, A. L., Stockmann, C., Rubinstein, M. P., Liao, D., Zhang, N., DeNardo, D. G., Coussens, L. M., Karin, M., Goldrath, A. W., & Johnson, R. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1439 · Cited by 652
Finlay, D. K., Rosenzweig, E., Sinclair, L. V., Feijoo-Carnero, C., Hukelmann, J. L., Rolf, J., Panteleyev, A. A., Okkenhaug, K., & Cantrell, D. A. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112607 · Cited by 596
Rausch, M. E., Weisberg, S., Vardhana, P., & Tortoriello, D. V. (2008) · International Journal of Obesity · doi:10.1038/sj.ijo.0803744 · Cited by 585
Clambey, E. T., McNamee, E. N., Westrich, J. A., Glover, L. E., Campbell, E. L., Jedlicka, P., de Zoeten, E. F., Cambier, J. C., Stenmark, K. R., Colgan, S. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202366109 · Cited by 560 · cited 2×
“Under hypoxic stress and in the presence of TGF- , CD4 T cells upregulate Foxp3 through direct binding of HIF-1 to the Foxp3 promoter region, inducing Treg cell formation (18).”
BackgroundHIF Induces Human Embryonic Stem Cell Markers in Cancer Cells
Mathieu, J., Zhang, Z., Zhou, W., Wang, A. J., Heddleston, J. M., Pinna, C. M. A., Hubaud, A., Stadler, B., Choi, M., Bar, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3320 · Cited by 508
Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis
Rodig, N., Ryan, T., Allen, J. A., Pang, H., Grabie, N., Chernova, T., Greenfield, E. A., Liang, S. C., Sharpe, A. H., Lichtman, A. H., et al. (2003) · European Journal of Immunology · doi:10.1002/eji.200324270 · Cited by 492
Allavena, P., Piemonti, L., Longoni, D., Bernasconi, S., Stoppacciaro, A., Ruco, L., & Mantovani, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199801)28:01<359::aid-immu359>3.0.co;2-4 · Cited by 486
A molecular role for lysyl oxidase‐like 2 enzyme in Snail regulation and tumor progression
Peinado, H., del Carmen Iglesias‐de la Cruz, M., Olmeda, D., Csiszar, K., Fong, K. S., Vega, S., Nieto, M. A., Cano, A., & Portillo, F. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600781 · Cited by 446
Caldwell, C. C., Kojima, H., Lukashev, D., Armstrong, J., Farber, M., Apasov, S. G., & Sitkovsky, M. V. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6140 · Cited by 420
Targeting HIF1α Eliminates Cancer Stem Cells in Hematological Malignancies
Wang, Y., Liu, Y., Malek, S. N., Zheng, P., & Liu, Y. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.02.006 · Cited by 410 · cited 1×
“(116) using human acute lymphocytic leukemia showed a selective activation of HIF-1 in leukemia stem cells under normoxic conditions compared with the bulk of leukemia blasts.”
BackgroundTumor Vessel Normalization by Chloroquine Independent of Autophagy
Maes, H., Kuchnio, A., Peric, A., Moens, S., Nys, K., De Bock, K., Quaegebeur, A., Schoors, S., Georgiadou, M., Wouters, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.025 · Cited by 410
Jögi, A., Øra, I., Nilsson, H., Lindeheim, Å., Makino, Y., Poellinger, L., Axelson, H., & Påhlman, S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102660199 · Cited by 399
Mak, P., Leav, I., Pursell, B., Bae, D., Yang, X., Taglienti, C. A., Gouvin, L. M., Sharma, V. M., & Mercurio, A. M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.02.030 · Cited by 372
Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1304790110 · Cited by 344
Self-citationSemenza, G. L. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21523 · Cited by 317
Tartour, E., Pere, H., Maillere, B., Terme, M., Merillon, N., Taieb, J., Sandoval, F., Quintin-Colonna, F., Lacerda, K., Karadimou, A., et al. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9281-4 · Cited by 316
The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients
Osada, T., Chong, G., Tansik, R., Hong, T., Spector, N., Kumar, R., Hurwitz, H. I., Dev, I., Nixon, A. B., Lyerly, H. K., et al. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0441-x · Cited by 311
Jung, H.-Y., Fattet, L., & Yang, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3173 · Cited by 309
Akalay, I., Janji, B., Hasmim, M., Noman, M. Z., André, F., De Cremoux, P., Bertheau, P., Badoual, C., Vielh, P., Larsen, A. K., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2432 · Cited by 302
Self-citationAzab, A. K., Hu, J., Quang, P., Azab, F., Pitsillides, C., Awwad, R., Thompson, B., Maiso, P., Sun, J. D., Hart, C. P., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380410 · Cited by 301
Zhang, L., Huang, G., Li, X., Zhang, Y., Jiang, Y., Shen, J., Liu, J., Wang, Q., Zhu, J., Feng, X., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-108 · Cited by 293
Endothelial Programmed Death-1 Ligand 1 (PD-L1) Regulates CD8 + T-Cell–Mediated Injury in the Heart
Grabie, N., Gotsman, I., DaCosta, R., Pang, H., Stavrakis, G., Butte, M. J., Keir, M. E., Freeman, G. J., Sharpe, A. H., & Lichtman, A. H. (2007) · Circulation · doi:10.1161/circulationaha.107.709360 · Cited by 288
Hypoxia-Induced Gene Expression in Human Macrophages
Burke, B., Giannoudis, A., Corke, K. P., Gill, D., Wells, M., Ziegler-Heitbrock, L., & Lewis, C. E. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63483-9 · Cited by 286
Zhang, W., Shi, X., Peng, Y., Wu, M., Zhang, P., Xie, R., Wu, Y., Yan, Q., Liu, S., & Wang, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129603 · Cited by 261
Noman, M. Z., Janji, B., Kaminska, B., Van Moer, K., Pierson, S., Przanowski, P., Buart, S., Berchem, G., Romero, P., Mami-Chouaib, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1094 · Cited by 256
Self-citationMcCord, A. M., Jamal, M., Shankavarum, U. T., Lang, F. F., Camphausen, K., & Tofilon, P. J. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0360 · Cited by 239
Hypoxia-Inducible Factor as an Angiogenic Master Switch
Hashimoto, T., & Shibasaki, F. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2015.00033 · Cited by 231
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
Multiple functions of Notch signaling in self‐renewing organs and cancer
Wilson, A., & Radtke, F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.03.024 · Cited by 217
Lee, J. H., Elly, C., Park, Y., & Liu, Y.-C. (2015) · Immunity · doi:10.1016/j.immuni.2015.05.016 · Cited by 203
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
Noh, K. H., Kim, B. W., Song, K.-H., Cho, H., Lee, Y.-H., Kim, J. H., Chung, J.-Y., Kim, J.-H., Hewitt, S. M., Seong, S.-Y., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64057 · Cited by 194
Barsoum, I. B., Hamilton, T. K., Li, X., Cotechini, T., Miles, E. A., Siemens, D. R., & Graham, C. H. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2104 · Cited by 188
Palazón, A., Martínez-Forero, I., Teijeira, A., Morales-Kastresana, A., Alfaro, C., Sanmamed, M. F., Perez-Gracia, J. L., Peñuelas, I., Hervás-Stubbs, S., Rouzaut, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0314 · Cited by 187
Divergent effects of hypoxia on dendritic cell functions
Mancino, A., Schioppa, T., Larghi, P., Pasqualini, F., Nebuloni, M., Chen, I.-H., Sozzani, S., Austyn, J. M., Mantovani, A., & Sica, A. (2008) · Blood · doi:10.1182/blood-2008-02-142091 · Cited by 184
Noman, M. Z., Buart, S., Van Pelt, J., Richon, C., Hasmim, M., Leleu, N., Suchorska, W. M., Jalil, A., Lecluse, Y., El Hage, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800854 · Cited by 183
Self-citationRicciardi, M., Zanotto, M., Malpeli, G., Bassi, G., Perbellini, O., Chilosi, M., Bifari, F., & Krampera, M. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.29 · Cited by 182
Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
Lundgren, K., Nordenskjöld, B., & Landberg, G. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605369 · Cited by 171
Werno, C., Menrad, H., Weigert, A., Dehne, N., Goerdt, S., Schledzewski, K., Kzhyshkowska, J., & Brune, B. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq088 · Cited by 167
Dawood, S., Broglio, K., Valero, V., Reuben, J., Handy, B., Islam, R., Jackson, S., Hortobagyi, G. N., Fritsche, H., & Cristofanilli, M. (2008) · Cancer · doi:10.1002/cncr.23852 · Cited by 163
Chen, Y., Marco, M. A. D., Graziani, I., Gazdar, A. F., Strack, P. R., Miele, L., & Bocchetta, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1229 · Cited by 163
Targeting the HIF pathway in inflammation and immunity
Scholz, C. C., & Taylor, C. T. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.04.009 · Cited by 161
Nakamura, H., Makino, Y., Okamoto, K., Poellinger, L., Ohnuma, K., Morimoto, C., & Tanaka, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7592 · Cited by 158
Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis
Fingleton, B., Vargo-Gogola, T., Crawford, H. C., & Matrisian, L. M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900190 · Cited by 158
White, J. R., Harris, R. A., Lee, S. R., Craigon, M., Binley, K., Price, T., Beard, G. L., Mundy, C. R., & Naylor, S. (2003) · Genomics · doi:10.1016/s0888-7543(03)00215-5 · Cited by 154
Kallergi, G., Markomanolaki, H., Giannoukaraki, V., Papadaki, M. A., Strati, A. D., Lianidou, E. S., Georgoulias, V., Mavroudis, D., & Agelaki, S. (2009) · Breast Cancer Research · doi:10.1186/bcr2452 · Cited by 152
Circulating tumour cells demonstrate an altered response to hypoxia and an aggressive phenotype
Ameri, K., Luong, R. H., Zhang, H., Powell, A. A., Montgomery, K. D., Espinosa, Í., Bouley, D. M., Harris, A. L., & Jeffrey, S. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605491 · Cited by 148
Efficient Treg depletion induces T‐cell infiltration and rejection of large tumors
Li, X., Kostareli, E., Suffner, J., Garbi, N., & Hämmerling, G. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041093 · Cited by 141
Salnikov, A. V., Liu, L., Platen, M., Gladkich, J., Salnikova, O. V., Ryschich, E., Mattern, J., Moldenhauer, G., Werner, J., Schemmer, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046391 · Cited by 132
Epithelial–Mesenchymal Transition Induces an Antitumor Immune Response Mediated by NKG2D Receptor
López‐Soto, A., Huergo-Zapico, L., Galván, J. A., Rodrigo, L., de Herreros, A. G., Astudillo, A., & Gonzalez, S. R. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202950 · Cited by 131
Takayama, T., Morelli, A. E., Onai, N., Hirao, M., Matsushima, K., Tahara, H., & Thomson, A. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7136 · Cited by 130
FM19G11, a New Hypoxia-inducible Factor (HIF) Modulator, Affects Stem Cell Differentiation Status
Moreno‐Manzano, V., Rodríguez-Jiménez, F. J., Aceña, J. L., Fustero, S., Erceg, S., Dopazo, J., Montaner, D. A., Stojković, M., & Sánchez-Puelles, J.-M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.008326 · Cited by 129
Hypoxia-inducible factors: crosstalk between inflammation and metabolism
Shay, J. E. S., & Celeste Simon, M. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.04.004 · Cited by 122
Liu, G., Bi, Y., Xue, L., Zhang, Y., Yang, H., Chen, X., Lu, Y., Zhang, Z., Liu, H., Wang, X. Q., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420419112 · Cited by 122
Xiang, L., Gilkes, D. M., Hu, H., Takano, N., Luo, W., Lu, H., Bullen, J. W., Samanta, D., Liang, H., & Semenza, G. L. (2014) · Oncotarget · doi:10.18632/oncotarget.2997 · Cited by 119
ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
Messai, Y., Noman, M. Z., Hasmim, M., Janji, B., Tittarelli, A., Boutet, M., Baud, V., Viry, E., Billot, K., Nanbakhsh, A., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0303 · Cited by 119
Self-citationHIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery
Semenza, G. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209789649402 · Cited by 116 · cited 7×
“HIFs are dimeric proteins composed of an O2-sensitive -subunit (HIF-1 , HIF-2 , or HIF-3 ) and a -subunit (HIF-1 /aryl hydrocarbon receptor nuclear translocator).”
BackgroundInfluentialPietras, A., Gisselsson, D., Øra, I., Noguera, R., Beckman, S., Navarro, S., & Påhlman, S. (2008) · The Journal of Pathology · doi:10.1002/path.2304 · Cited by 116
Hasmim, M., Noman, M. Z., Messai, Y., Bordereaux, D., Gros, G., Baud, V., & Chouaïb, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1302140 · Cited by 115
Self-citationLukashev, D. E., Caldwell, C. C., Ohta, A., Chen, P., & Sitkovsky, M. V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104782200 · Cited by 104
Noman, M. Z., Messai, Y., Carré, T., Akalay, I., Meron, M., Janji, B., Hasmim, M., & Chouaı̈b, S. (2011) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v31.i5.10 · Cited by 104
Self-citationMondini, M., Nizard, M., Tran, T., Mauge, L., Loi, M., Clémenson, C., Dugué, D., Maroun, P., Louvet, E., Adam, J., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1015 · Cited by 104
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
Matsuoka, J., Yashiro, M., Doi, Y., Fuyuhiro, Y., Kato, Y., Shinto, O., Noda, S., Kashiwagi, S., Aomatsu, N., Hirakawa, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062310 · Cited by 99
In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment
Ohta, A., Diwanji, R., Kini, R., Subramanian, M., Ohta, A., & Sitkovsky, M. V. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00027 · Cited by 93
Autophagic degradation of GZMB/granzyme B
Viry, E., Bagińska, J., Berchem, G., Noman, M. Z., Medves, S., Chouaı̈b, S., & Janji, B. (2013) · Autophagy · doi:10.4161/auto.26924 · Cited by 92
Self-citationSun, L., Li, H., Chen, J., Iwasaki, Y., Kubota, T., Matsuoka, M., Shen, A., Chen, Q., & Xu, Y. (2013) · Journal of Cell Science · doi:10.1242/jcs.127381 · Cited by 88
EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction
Akalay, I., Janji, B., Hasmim, M., Noman, M. Z., Thiery, J. P., Mami‐Chouaib, F., & Chouaïb, S. (2013) · Autophagy · doi:10.4161/auto.24728 · Cited by 84
Self-citationHuang, J., Yao, X., Zhang, J., Dong, B., Chen, Q., Xue, W., Liu, D., & Huang, Y. (2013) · Cancer Science · doi:10.1111/cas.12291 · Cited by 78
Scortegagna, M., Martin, R. J., Kladney, R. D., Neumann, R. G., & Arbeit, J. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3643 · Cited by 77
Hypoxia-induced autophagy: A new player in cancer immunotherapy?
Noman, M. Z., Janji, B., Berchem, G., Mami‐Chouaib, F., & Chouaïb, S. (2012) · Autophagy · doi:10.4161/auto.19572 · Cited by 71
Self-citationHasmim, M., Noman, M. Z., Lauriol, J., Benlalam, H., Mallavialle, A., Rosselli, F., Mami‐Chouaib, F., Alcaïde‐Loridan, C., & Chouaïb, S. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101011 · Cited by 71
Self-citationTargeting hypoxia at the forefront of anticancer immune responses
Noman, M. Z., & Chouaib, S. (2014) · OncoImmunology · doi:10.4161/21624011.2014.954463 · Cited by 70
Self-citation(2000) · doi:10.1002/1096-9896(2000)9999:9999 · Cited by 70
Akalay, I., Tan, T. Z., Kumar, P., Janji, B., Mami‐Chouaib, F., Charpy, C., Vielh, P. R., Larsen, A. K., Thiery, J. P., Sabbah, M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.151 · Cited by 68
Self-citationKiéda, C., Hafny‐Rahbi, B. E., Collet, G., Lamerant‐Fayel, N., Grillon, C., Guichard, A., Dulak, J., Józkowicz, A., Kotlinowski, J., Fylaktakidou, K. C., et al. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0992-6 · Cited by 68
Cheng, Z., Wang, D., LIU, T., Liu, W., Xia, W.-B., XU, J., ZHANG, Y.-H., Qu, Y., Guo, L., Ding, L., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3022 · Cited by 65
Cancer stem cell characteristics of circulating tumor cells
Tinhofer, I., Saki, M. R., Niehr, F., Keilholz, U., & Budach, V. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.886798 · Cited by 63
Persistent vascular normalization as an alternative goal of anti‐angiogenic cancer therapy
Sato, Y. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01929.x · Cited by 61
Monitoring Serial Changes in Circulating Human Breast Cancer Cells in Murine Xenograft Models
Eliane, J.-P., Repollet, M., Luker, K. E., Brown, M. E., Rae, J. M., Dontu, G., Schott, A. F., Wicha, M. S., Doyle, G. V., Hayes, D. F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0630 · Cited by 49
Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
Collet, G., Lamerant‐Fayel, N., Tertil, M., Hafny‐Rahbi, B. E., Stępniewski, J., Guichard, A., Foucault‐Collet, A., Klimkiewicz, K., Pètoud, S., Matejuk, A., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0637 · Cited by 48
Collet, G., Skrzypek, K., Grillon, C., Matejuk, A., Hafny‐Rahbi, B. E., Lamerant‐Fayel, N., & Kiéda, C. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.03.001 · Cited by 46
The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing
Messai, Y., Noman, M. Z., Janji, B., Hasmim, M., Escudier, B. J., & Chouaı̈b, S. (2015) · Autophagy · doi:10.1080/15548627.2015.1017194 · Cited by 44
Self-citationTrojan horse at cellular level for tumor gene therapies
Collet, G., Grillon, C., Nadim, M., & Kiéda, C. (2013) · Gene · doi:10.1016/j.gene.2013.03.057 · Cited by 42
News on microenvironmental physioxia to revisit skin cell targeting approaches
Grillon, C., Matejuk, A., Nadim, M., Lamerant‐Fayel, N., & Kiéda, C. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01551.x · Cited by 20
HIF-2α/ITPR1 axis: A new saboteur of NK-mediated lysis
Messai, Y., Noman, M. Z., Hasmim, M., Escudier, B. J., & Chouaı̈b, S. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.985951 · Cited by 19
Self-citationImmunothérapie du cancer : espoirs et réalités
Chouaı̈b, S., Hage, F. E., Benlalam, H., & Mami‐Chouaib, F. (2006) · médecine/sciences · doi:10.1051/medsci/20062289755 · Cited by 14
Yu, L., Zhou, L., Li, M., Li, Z., Wang, D., & Zhang, S. (2012) · Oncology Reports · doi:10.3892/or.2012.2103 · Cited by 11
Gong, Y., Tan, W., Lin, J. M., Huang, M., Wood, C. G., & Wu, X. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-4640 · Cited by 10
Cited by
The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy
Muz, B., de la Puente, P., Azab, F., & Azab, A. K. (2015) · Hypoxia · doi:10.2147/hp.s93413 · Cited by 2,066
“resistance and immune-suppression, which help tumor cells to escape from immune surveillance.(117,118) Some of the”
BackgroundIntratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Marusyk, A., Janiszewska, M., & Polyak, K. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.007 · Cited by 1,009
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 682
Molecular landmarks of tumor hypoxia across cancer types
Bhandari, V., Hoey, C., Liu, L. Y., Lalonde, E., Ray, J., Livingstone, J., Lesurf, R., Shiah, Y.-J., Vujcic, T., Huang, X., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0318-2 · Cited by 678
Metadata
- Authors
- Noman, M. Z., Hasmim, M., Messai, Y., Terry, S., Kieda, C., Janji, B., & Chouaib, S.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2015-11-01
- Volume
- 309
- Issue
- 9
- Pages
- C569-C579
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2138378181
- Cited by
- 400
- References
- 129
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.